Liver transplantation from donors aged 80 years and over: Pushing the limit

被引:113
作者
Nardo, B [1 ]
Masetti, M
Urbani, L
Caraceni, P
Montalti, R
Filipponi, F
Mosca, F
Martinelli, G
Bernardi, M
Pinna, AD
Cavallari, A
机构
[1] Univ Bologna, Dept Surg & Transplantat, Bologna, Italy
[2] Univ Modena, Dept Surg & Transplantat, I-41100 Modena, Italy
[3] Univ Pisa, Dept Surg & Transplantat, Pisa, Italy
[4] Univ Bologna, Dept Internal Med Cardioangiol Hepatol, Bologna, Italy
[5] Univ Bologna, Dept Intens Care Unit, Bologna, Italy
关键词
hepatitis C; liver transplantation; old donors;
D O I
10.1111/j.1600-6143.2004.00472.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Older donors are a growing part of the total donor pool but no definite consensus exists on the limit of age for their acceptance. From November 1998 to January 2003, in a retrospective case-control multicenter study, we compared the outcome of 30 orthotopic liver transplantations (OLTs) with octogenarian donors and of 60 chronologically correlated OLTs performed with donors <40 years. The percentage of refusal was greater among older than younger donors (48.2 vs. 14.3%; p < 0.001). Cold ischemia was significantly shorter in the older than younger groups. Recipients with hepatocarcinoma and older age received octogenarian grafts more frequently. No differences were seen in post-operative complications and 6-month graft and patient survival. However, long-term survival was lower in patients transplanted with octogenarian donors (p = 0.04). Interestingly, the mortality related to hepatitis C recurrence was greater in patients with octogenarian donors. Accordingly, the long-term survival of HCV-positive patients who received older grafts was lower than those receiving younger grafts (p = 0.05). Octogenarian livers can be used safely but a careful donor evaluation and a short cold ischemia are required to prevent additional risk factors. However, hepatitis C recurrence is associated with a greater mortality in patients who received octogenarian grafts raising concerns whether to allocate these livers to HCV-positive recipients.
引用
收藏
页码:1139 / 1147
页数:9
相关论文
共 37 条
[31]   Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C [J].
Wali, M ;
Harrison, RF ;
Gow, PJ ;
Mutimer, D .
GUT, 2002, 51 (02) :248-252
[32]   ELDERLY LIVER-DONOR [J].
WALL, W ;
GRANT, D ;
ROY, A ;
ASFAR, S ;
BLOCK, M .
LANCET, 1993, 341 (8837) :121-121
[33]   THE USE OF OLDER DONOR LIVERS FOR HEPATIC TRANSPLANTATION [J].
WALL, WJ ;
MIMEAULT, R ;
GRANT, DR ;
BLOCH, M .
TRANSPLANTATION, 1990, 49 (02) :377-381
[34]   Graft function and outcome of older (>=60 years) donor livers [J].
Washburn, WK ;
Johnson, LB ;
Lewis, WD ;
Jenkins, RL .
TRANSPLANTATION, 1996, 61 (07) :1062-1066
[35]   Model for End-Stage Liver Disease (MELD) and allocation of donor livers [J].
Wiesner, R ;
Edwards, E ;
Freeman, R ;
Harper, A ;
Kim, R ;
Kamath, P ;
Kremers, W ;
Lake, J ;
Howard, T ;
Merion, RM ;
Wolfe, RA ;
Krom, R .
GASTROENTEROLOGY, 2003, 124 (01) :91-96
[36]  
Wight C, 1996, BRIT MED J, V312, P989
[37]   THE AGING LIVER [J].
WYNNE, HA ;
JAMES, OFW .
AGE AND AGEING, 1990, 19 (01) :1-3